HighMark Wealth Management’s Transmedics TMDX Stock Holding History

HighMark Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.72K	Hold	41	–	–	﹤0.01%	442
2026 Q1	$4.07K	Buy	41 +1	+3%	+$130	﹤0.01%	403
2025 Q4	$4.87K	Hold	40	–	–	﹤0.01%	408
2025 Q3	$4.49K	Hold	40	–	–	﹤0.01%	411
2025 Q2	$5.36K	Hold	40	–	–	﹤0.01%	388
2025 Q1	$2.69K	Hold	40	–	–	﹤0.01%	430
2024 Q4	$2.49K	Hold	40	–	–	﹤0.01%	443
2024 Q3	$6.28K	Hold	40	–	–	﹤0.01%	373
2024 Q2	$6.03K	Hold	40	–	–	﹤0.01%	359
2024 Q1	$2.96K	Hold	40	–	–	﹤0.01%	425
2023 Q4	$3.16K	Hold	40	–	–	﹤0.01%	420
2023 Q3	$2.19K	Hold	40	–	–	﹤0.01%	445
2023 Q2	$3.36K	Buy	+40	New	+$3.06K	﹤0.01%	405

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

HighMark Wealth Management's TMDX Position: Q2 2026 in Review

HighMark Wealth Management held its Transmedics (TMDX) position steady in Q2 2026 at 41 shares worth $2.72K. The position accounts for ﹤0.01% of the portfolio, ranked #442.

HighMark Wealth Management first reported a position in TMDX in Q2 2023 and has held it in 13 quarters since. The position peaked at $6.28K in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

HighMark Wealth Management held 41 shares of Transmedics worth $2.72K as of Q2 2026.
HighMark Wealth Management left its Transmedics share count unchanged in Q2 2026.
Transmedics made up ﹤0.01% of HighMark Wealth Management's portfolio in Q2 2026, its #442 holding.
HighMark Wealth Management first reported a position in Transmedics in Q2 2023 and has held it in 13 quarters since.
HighMark Wealth Management's Transmedics position peaked at $6.28K in Q3 2024.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.